| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |